US Material Events SEC 8-K Filings — September 10, 2026

10-09-2026

Trustmark Bank entered into a definitive agreement to sell 34 bank branch properties for $91.7 million to entities affiliated with Blue Owl Real Estate Capital LLC, and simultaneously lease them back under 15-year triple-net leases with 1.50% annual rent escalations. The sale-leaseback transaction closed on the effective date of September 3, 2026, allowing Trustmark to unlock real estate capital while continuing to operate its branches as tenant.

• · The buyer is a Delaware limited liability company (or entities) listed on Exhibit E, with Blue Owl Real Estate Capital LLC as the affiliate referenced in the Right of Replacement Side Letter.
• · Seller delivered Phase I environmental reports, title commitments, ALTA surveys, and zoning reports for each property at its cost, subject to partial reimbursement by buyer at closing.
• · The properties are sold 'as-is, where-is' with no express or implied warranties beyond those in the agreement and closing documents.
• · Seller's representations are based on the actual knowledge of Mel Channel, Director of Corporate Facilities and Security, without any duty of inquiry.
• · The transaction includes a Right of Replacement Side Letter allowing buyer to substitute properties under certain conditions.

10-09-2026

Public Storage (PSA-PG) entered into an underwriting agreement on September 9, 2026, to issue C$400 million aggregate principal amount of 4.540% senior notes due 2033 through its subsidiary PS Canada Finance ULC, guaranteed by the Company and PSOC. The offering is expected to close on September 16, 2026, with net proceeds used to replenish cash for the Public Storage Canada acquisition and for general corporate purposes. No period-over-period comparisons are available as this is a new debt issuance event.

• · The Notes will be issued at par value and mature on September 16, 2033.
• · Interest on the Notes will be paid semi-annually on March 16 and September 16, commencing March 16, 2027.
• · The offering was made under shelf registration statement on Form S-3 (File Nos. 333-283556, 333-283556-01 and 333-283556-02), amended via a post-effective amendment filed on September 8, 2026.
• · A preliminary prospectus supplement was filed with the SEC on September 9, 2026 under Rule 424(b)(5).
• · Net proceeds will also be used for investments in self-storage facilities, repayment of debt, and redemption of outstanding securities.

10-09-2026

Mexco Energy Corporation held its 2026 Annual Meeting on September 8, 2026, where stockholders elected five directors, ratified Weaver & Tidwell as auditor, approved the amended 2019 employee incentive stock plan, and approved a non-binding advisory vote on executive compensation. All proposals received strong support, with the incentive plan passing by 1,538,624 votes for versus 67,868 against. The company also disclosed amendments to the incentive plan and related award agreements.

• · The company had 2,046,000 shares of common stock outstanding and entitled to vote as of July 20, 2026.
• · 1,649,149 shares (constituting a quorum) were represented at the meeting.
• · All five director nominees received over 1.6 million votes for, with less than 16,000 votes withheld each.
• · Ratification of auditor was overwhelmingly approved: 1,634,808 for, 14,334 against, and 7 abstained.
• · The compensated advisory vote on executive compensation passed: 1,593,300 for, 6,173 against, 16,735 abstained.
• · The incentive stock plan was approved with 1,538,624 votes for, 67,868 against, and 9,716 abstained.

10-09-2026

Copart, Inc. (NASDAQ: CPRT) announced a definitive agreement to acquire all outstanding shares of ACV Auctions Inc. (NYSE: ACVA) for $10.50 per share in cash, implying an equity value of approximately $1.9 billion. The offer represents a premium of approximately 45% over ACV's unaffected closing price on August 10, 2026, and approximately 41% over its 30-day VWAP. The transaction is expected to be neutral to Copart's EPS in the first full year and accretive in fiscal 2028 and beyond, with expected cost and revenue synergies. However, the deal is subject to regulatory approvals and tender conditions, and there are risks related to integration and potential competing offers.

• · The transaction is expected to close by calendar year-end 2026.
• · The tender offer is subject to the tender of at least a majority of ACV's outstanding shares and HSR waiting period expiration.
• · ACV will operate as an independent subsidiary of Copart led by ACV's existing leadership team.
• · Copart intends to fund the transaction with cash on hand; no financing condition.
• · Copart reported its Q4 and full fiscal year 2026 financial results in a separate release.
• · Conference call scheduled for 5:30 p.m. Eastern Time today.

10-09-2026

Axogen, Inc. (AXGN) has entered into a definitive agreement to acquire BioCircuit Technologies for $200 million in cash, adding NerveTape™, the first FDA-approved sutureless nerve repair device. The transaction is expected to close in Q4 2026 and to be accretive to revenue growth, adjusted EBITDA margin, and adjusted EPS in the first year post-close, while Axogen maintains positive free cash flow. The acquisition is funded by net proceeds from a concurrent public offering of common stock.

• · Transaction approved by the Boards of Directors of both Axogen and BioCircuit.
• · Closing is subject to customary conditions, including spin-out of BioCircuit's electronics R&D business.
• · Axogen will provide updated full-year 2026 guidance after closing; full-year 2027 guidance will be provided in Q1 2027.
• · Axogen expects the acquisition to be additive to 2027 revenue with accretion to gross margin and adjusted EBITDA margin.
• · Conference call scheduled for September 10, 2026 at 8:00am ET.

10-09-2026

Indaptus Therapeutics raised approximately $24.0 million in gross proceeds through a private placement of 20,338,974 shares of common stock priced at the Nasdaq Minimum Price plus $0.015 per share. The company plans to use the net proceeds for working capital, R&D, and general corporate purposes, including early-stage research on a potential neurotechnology and neural-network-based device for sleep-related conditions. A resale registration statement will be filed with the SEC following closing.

• · The purchase price per share equals the Nasdaq Minimum Price plus $0.015 per share.
• · Closing is subject to customary conditions and must occur no later than the fifteenth business day following September 8, 2026.
• · The shares were issued in reliance on exemptions under Section 4(a)(2) of the Securities Act and/or Regulation S.
• · The company intends to file a resale registration statement with the SEC using commercially reasonable efforts.

10-09-2026

Group 1 Automotive has priced a $1.25B senior notes offering ($625M each of 6.250% notes due 2032 and 6.625% notes due 2035) to fund its pending Hennessy Acquisition. Proceeds will initially repay revolver borrowings and be reborrowed at acquisition close. The notes include a special mandatory redemption if the acquisition is not completed by January 6, 2027.

• · The notes are unregistered private placements under Rule 144A and Regulation S.
• · Special mandatory redemption triggers if Hennessy Acquisition is not closed by the later of January 6, 2027 or any extension of the Outside Date.
• · If acquisition fails, proceeds will repay revolver borrowings and be used for general corporate purposes.
• · The offering is expected to close on September 22, 2026.

10-09-2026

PAVmed Inc. entered into a Sales Agreement with A.G.P./Alliance Global Partners on September 9, 2026, to conduct an at-the-market offering of up to $9.4 million of its common stock. The company will pay a 3.0% commission on gross sales and reimburse certain legal fees, with net proceeds intended for working capital and general corporate purposes. The filing does not disclose any prior-period comparisons or financial performance metrics.

• · The shelf registration statement (File No. 333-283994) was declared effective by the SEC on April 15, 2025.
• · The prospectus supplement was filed with the SEC on September 9, 2026.
• · The Agreement may be terminated by either party with ten business days' written notice, or by the Agent immediately in certain circumstances.

10-09-2026

STAAR Surgical appointed former CEO David Bailey as Chief Commercial Officer, effective September 8, 2026. Bailey, who led the company from 2001 to 2011 and raised over $60 million, returns to drive revenue growth as EVO ICL gains share from a declining laser refractive market. The appointment underscores STAAR's strategic focus on expanding its phakic IOL leadership amid stagnating laser procedures globally.

• · Bailey served as President and CEO from 2001 to 2008 and as President of International Operations from 2008 to 2011.
• · He secured landmark FDA approval of the ICL in 2005.
• · He directed commercial launches in China, South Korea, and across Asia.
• · He acquired STAAR's Canon joint venture in Japan, securing exclusive control of patents and proprietary technology worldwide.
• · ICL revenues have grown more than tenfold since 2011 (from ~$32M).
• · Bailey will attend the 44th Congress of the ESCRS in London from September 11–15, 2026.
• · STAAR has sold more than 4 million ICLs in over 85 countries.
• · The company operates facilities in California and Switzerland.

10-09-2026

Principal Financial Group Inc. (PFG) announced that its subsidiary, Principal Life Insurance Company, entered into an amended and restated five-year credit agreement dated September 9, 2026, providing a $900 million revolving credit facility. The facility is guaranteed by PFG and Principal Financial Services, Inc., and replaces the existing credit agreement from October 2022. The agreement includes customary terms and conditions, with interest rates tied to the borrower's financial strength ratings.

• · The credit agreement is a five-year facility dated September 9, 2026.
• · The facility replaces an existing credit agreement dated October 18, 2022.
• · Interest rates are based on the Applicable Financial Strength Rating of Principal Life Insurance Company, with initial pricing at Pricing Level 3 (A+/A1/A+).
• · The agreement includes a commitment fee ranging from 0.060% to 0.125% per annum depending on the rating level.
• · The facility is guaranteed by Principal Financial Group, Inc. and Principal Financial Services, Inc.

10-09-2026

Swarmer, Inc. (NASDAQ: SWMR) announced a definitive agreement to acquire Ratel Robotics, a Ukrainian UGV manufacturer, for up to $224 million in cash and stock. The acquisition expands Swarmer's platform with Ratel's combat-proven UGVs and brings over 300 employees, growing the pro forma company to nearly 500. Ratel has secured $86 million in contracts this year and holds a 37% share of Ukrainian UGV procurement spending, but the deal is subject to customary closing conditions and regulatory approvals.

• · Ratel Robotics' products carry NATO stock numbers under NCAGE code A3X8J and AQAP 2110 certification.
• · Swarmer's technology has been deployed in combat operations in Ukraine since April 2024 and has completed over 100,000 missions.
• · Swarmer maintains operations in Ukraine, Poland, and Estonia.
• · The acquisition is Swarmer's first major acquisition under board chairman Erik Prince.

10-09-2026

Cooper-Standard Holdings Inc. entered into Amendment No. 6 to its ABL credit agreement on September 3, 2026, increasing total commitments by $20M to $200M and extending the maturity date to September 3, 2031. The amendment also lowered applicable interest rate margins by removing credit spread adjustments and reducing spreads to a range of 150-200 bps for SOFR/CORRA borrowings and 50-100 bps for base/prime rate borrowings. This refinancing improves liquidity and reduces borrowing costs, but the company remains leveraged with a $200M facility.

• · The amendment removed credit spread adjustments with respect to SOFR and CORRA, further reducing borrowing costs.
• · The maturity date was extended to September 3, 2031, providing long-term stability.
• · The increased commitments may be allocated between U.S. and Canadian facility amounts.
• · The applicable margin is based on a grid tied to average quarterly availability.

10-09-2026

Chemours, along with DuPont and Corteva, reached a $455 million settlement with North Carolina and 11 local entities to resolve PFAS-related litigation. Chemours' 50% share is approximately $180 million on a net present value basis, which is covered by existing accruals, and the company expects to pay about $50 million over the next twelve months. The settlement acknowledges progress under the 2019 Consent Order and provides greater liability clarity, but the agreement remains subject to court dismissals and does not resolve all PFAS claims.

• · The settlement resolves litigations from the State of North Carolina and 11 local entities, including claims related to AFFF use.
• · The settlement acknowledges completion of several Consent Order provisions and establishes procedures for remaining off-site obligations.
• · All future contributions to the MOU escrow account are considered satisfied, including Chemours' $50 million escrow contribution due in September 2026.
• · The settlement does not resolve claims by North Carolina subdivisions not covered, personal injury, property damage, or natural resource damages claims.
• · The agreement remains subject to entry of dismissals of the covered litigations.

10-09-2026

1-800-FLOWERS.COM reported fiscal 2026 revenue of $1.50B (down 10.8% YoY) and a net loss of $134.8M, including a $45.2M non-cash goodwill impairment. Fourth-quarter revenue fell 12.9% to $293.1M, with net loss widening to $52.3M. The company amended its credit agreement for flexibility and is evaluating capital raising options, including asset sales, with Guggenheim Securities as advisor. For fiscal 2027, it expects mid-single-digit revenue decline and adjusted EBITDA of $10M-$15M.

• · Fiscal 2026 adjusted net loss was $77.5M ($1.21 per share) vs $52.5M ($0.82 per share) in fiscal 2025.
• · Q4 adjusted net loss was $51.6M ($0.80 per share) vs $43.8M ($0.69 per share) in Q4 FY25.
• · Q4 operating expenses decreased $16.7M YoY to $158.2M; excluding non-recurring items, down $8.9M to $150.8M.
• · Fiscal 2026 operating expenses decreased $158.6M to $698.5M; excluding non-recurring items, down $62.0M to $633.3M.
• · Gourmet Foods & Gift Baskets Q4 gross profit margin fell 830 bps to 17.7% due to deleveraging, tariffs, commodity and shipping costs.
• · Consumer Floral & Gifts Q4 gross profit margin improved 220 bps to 40.7% on lower commodity and shipping costs.
• · BloomNet Q4 gross profit margin improved 190 bps to 48.8%.
• · Fiscal 2027 revenue expected to decline mid-single digit range; adjusted EBITDA guidance $10M-$15M includes ~$12M additional compensation expense.
• · Company amended credit agreement for covenant relief and flexibility to use asset sale proceeds for strategic investments.
• · Company evaluating capital raising options including debt/equity financings and divestitures; Guggenheim Securities retained as advisor.

10-09-2026

DuPont, Chemours, and Corteva have reached a settlement with the State of North Carolina and 11 local entities to resolve PFAS-related claims, including historical discharges from the Fayetteville Works facility and AFFF-related contamination. The total settlement payments are $455 million over 15 years, with a net present value of approximately $355 million. DuPont's pre-tax share is about $126 million, of which 44% will be reimbursed by Qnity Electronics, and the amount is materially covered by existing accruals. The settlement also satisfies certain MOU escrow obligations, including the September 2026 contribution.

• · Settlement payments begin within 30 days of execution date.
• · The settlement resolves litigations from the State of North Carolina and 11 local entities excluded from the 2024 U.S. Public Water System Class Settlement.
• · The settlement also satisfies future MOU escrow contributions, including the September 2026 contribution.
• · The settlement agreement remains subject to entry of dismissals of the covered litigations.

10-09-2026

Mobileye Global Inc. announced on September 3, 2026, that its Board designated Chief Operating Officer Yaacov "Kobi" Ohayon as the principal operating officer and an executive officer under Section 16 of the Exchange Act. The change formalizes Mr. Ohayon's existing responsibilities, which have expanded since 2020, and does not modify his duties, employment status, or compensation. The filing reflects an internal governance adjustment with no financial impact on operations or performance.

• · Yaacov "Kobi" Ohayon, age 51, has been with Mobileye since 2017 and served as COO since 2020.
• · Ohayon entered into the company's standard form of officers' indemnification agreement.
• · No family relationships exist between Ohayon and any director or executive officer, and he is not party to any disclosable related-party transaction.

10-09-2026

Fortrea Holdings reinstated Jason Knoblauch as CFO and principal financial officer on September 9, 2026, following a settlement with his former employer that resolved a lawsuit alleging breach of restrictive covenants and retention of confidential information. David Smith, who served as Interim CFO during Knoblauch's leave, stepped down from that role but remains on the Board. The reinstatement follows a temporary restraining order issued by the Delaware Court of Chancery on July 25, 2026, which had prevented Knoblauch from serving as CFO.

• · The settlement agreement and mutual release resolved the lawsuit filed by Knoblauch's prior employer.
• · Knoblauch's compensation package remains unchanged from that disclosed in the June 26, 2026 Form 8-K.
• · The temporary restraining order was issued on July 25, 2026, and was lifted as part of the settlement.

10-09-2026

Pinnacle Financial Partners amended a non-compete and cooperation agreement with Harold R. Carpenter, extending the term through March 31, 2027. In exchange, the company will accelerate a $1,000,000 payment to October 1, 2026, and pay an additional $500,000 in March 2027. These payments are subject to forfeiture or clawback if Mr. Carpenter breaches the non-compete covenant.

• · The original letter agreement was dated January 14, 2026.
• · The non-compete and non-solicitation covenants now run through March 31, 2027.
• · Mr. Carpenter must also provide as-needed conversion-related assistance directed by Robert A. McCabe.
• · The previously scheduled payment date for the $1,000,000 second installment was on or after January 1, 2027.

10-09-2026

Village Farms International appointed Hamid Shekarchi as Interim CFO, effective immediately, succeeding Steve Ruffini who remains on the leadership team overseeing M&A. Shekarchi, previously CFO of the company's Canadian cannabis business, brings 18 years of financial leadership experience. The appointment follows a thorough search process as part of the previously announced CFO succession plan from April 3, 2026.

• · Shekarchi previously co-led BDO's Western Canada Cannabis practice and held senior roles at BDO Canada and PwC.
• · He is a Chartered Professional Accountant (CPA, CA) and Chartered Business Valuator (CBV).
• · He is a graduate of Simon Fraser University and a past recipient of Business in Vancouver's Forty Under 40 Award.
• · The company operates over 7 million square feet of advanced greenhouse and indoor cultivation assets.
• · Village Farms operates the world's largest EU-GMP certified cannabis facility in Delta, British Columbia.

10-09-2026

Insulet Corporation announced the departures of two directors from its Board. Timothy J. Scannell stepped down effective September 3, 2026, for health reasons after 12 years of service, including 7 years as Chairman. Michael R. Minogue also notified his resignation effective September 15, 2026, to focus on his candidacy for Governor of Massachusetts. Both departures were not due to any disagreement with the company's operations, policies, or practices.

10-09-2026

Tarsus Pharmaceuticals completed its acquisition of Alkeus Pharmaceuticals, adding worldwide rights to gildeuretinol (ALK-001), a Phase 3 investigational oral therapy for Stargardt disease, a rare inherited retinal disease with no FDA-approved treatment. The deal, announced August 6, 2026, closed September 4, 2026, and strengthens Tarsus' eye care pipeline. While the acquisition expands Tarsus' leadership in eye care, the asset is still in clinical development with topline data not expected until 2029, and the company faces the risk that anticipated benefits may not be realized.

• · ALK-001 has received Breakthrough Therapy, Orphan Drug, Fast Track, and Rare Pediatric Disease designations from the FDA for Stargardt disease.
• · Topline data from the NORTHSTAR Phase 3 trial is anticipated in 2029.
• · Tarsus' pipeline includes XDEMVY (FDA approved for Demodex blepharitis), TP-04 (Phase 2 for ocular rosacea), TP-05 (Phase 2 for Lyme disease prevention), and IRX-101 (ocular antiseptic).
• · The acquisition closed following satisfaction of customary closing conditions; no financial terms were disclosed.

10-09-2026

Two Harbors Investment Corp. (TWOD) announced the immediate departure of five senior officers on September 4, 2026, including the CFO, CIO, CLO, CRO, and CAO, all treated as Qualifying Terminations during a Change of Control Period under the company's Severance Benefits Plan. CEO William Greenberg will remain until October 2, 2026, when his employment is expected to terminate. Madhur Agarwal, CFO of parent company CrossCountry Mortgage, was appointed as TWO's CFO effective immediately, serving concurrently without additional compensation from TWO.

• · The departures are classified as 'Qualifying Termination' during a 'Change of Control Period' under the Two Harbors Investment Corp. Severance Benefits Plan, as amended and restated effective December 16, 2025.
• · Each departing officer has entered or is expected to enter into a customary separation and release agreement containing a general release of claims in favor of TWO.
• · Madhur Agarwal, age 36, has served as CFO of CrossCountry Mortgage since 2021 and will continue in that role concurrently.
• · Mr. Agarwal will not receive any compensation from TWO, and his CCM compensation will not be modified.
• · Mr. Agarwal holds an MBA from Harvard Business School and a B.S. from the University of Pennsylvania.
• · Mr. Agarwal has no material interests in transactions required to be disclosed under Item 404(a) of Regulation S-K.

10-09-2026

Jesse G. Singh resigned as a director of Carlisle Companies Incorporated effective September 10, 2026, due to a change in his employment, in accordance with the company's corporate governance guidelines. The Board reduced its size to six directors. Mr. Singh's resignation was not due to any disagreement with the company, and he served for over eight years.

• · Mr. Singh resigned at the conclusion of the Board meeting on September 10, 2026.
• · The resignation was due to a change in his employment, not a disagreement with the company.
• · The Board fixed the number of directors at six following the resignation.

10-09-2026

Friedman Industries Inc. entered into a Seventh Amendment to its Amended and Restated Credit Agreement with JPMorgan Chase Bank, increasing aggregate commitments from $140 million to $200 million, effective September 3, 2026. The expansion aligns the credit facility size with growth in the underlying borrowing base. No negative or flat performance metrics are reported in this filing.

• · The amendment was effective as of September 3, 2026.
• · Century Metals & Supplies, LLC is also a borrower under the credit agreement.
• · The full text of the Amendment will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ending September 30, 2026.
• · The A&R Credit Agreement was originally dated May 19, 2021.

10-09-2026

Graybar Electric Co Inc announced the retirement of Senior Vice President - Human Resources, Beverly L. Propst, effective January 1, 2027. Propst, who joined Graybar in 2002, will retire after a 24-year career with the company. The filing contains no financial results or quantitative performance data.

• · Propst joined Graybar in 2002 as Corporate Counsel, was promoted to Senior Corporate Counsel in 2003, named VP - Human Resources in 2008, and elected to the Board of Directors in 2009.
• · Graybar is a Fortune 500 corporation and one of the largest employee-owned companies in North America.
• · The company operates a network of 355 North American distribution facilities.

10-09-2026

Envirotech Vehicles, Inc. (now Azio AI Holdings, Inc.) dismissed its auditor Barton CPA, PLLC on September 3, 2026, and appointed TAAD LLP as its new independent registered public accounting firm on September 8, 2026. The change follows the company's acquisition of Legacy Azio AI on July 2, 2026, and is effective for the fiscal year ending December 31, 2026. While there were no disagreements with the former auditor, the company disclosed unremediated material weaknesses in internal controls over financial reporting related to staff reductions and reliance on outsourced help, and the former auditor's reports included a going-concern explanatory paragraph.

• · The company identified material weaknesses in internal control over financial reporting related to staff reductions and voluntary resignations beginning in Q4 2020, which remained unremediated as of December 31, 2025.
• · Barton's audit reports for fiscal years 2024 and 2025 included an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
• · TAAD LLP previously served as the independent auditor for Legacy Azio AI before its acquisition by the company on July 2, 2026.
• · The company did not consult with TAAD regarding any matters described in Items 304(a)(2)(i) and (ii) of Regulation S-K during the relevant periods.

10-09-2026

Dexcom appointed Glenn Boehnlein, former CFO of Stryker Corporation, to its Board of Directors effective September 10, 2026. Boehnlein brings over 20 years of MedTech financial leadership to the board, which will support the company's long-range plan execution. No financial metrics were disclosed in this filing.

• · Appointment effective September 10, 2026
• · Boehnlein served as Stryker's VP and CFO from 2016 to 2025 and as advisor to Stryker's CEO from 2025 to 2026
• · Boehnlein currently serves on boards of Inogen (Audit Committee Chair), Agilent Technologies, and Sutter Health
• · He holds bachelor's and master's degrees in professional accountancy from Mississippi State University

10-09-2026

Ingram Micro Holding Corporation announced a secondary offering of 13,125,000 shares by its principal stockholder, Ingram Holdco, LLC (an affiliate of Platinum Equity), with a concurrent stock repurchase of 625,000 shares by the company. The company will not receive any proceeds from the offering, but the repurchase is part of its existing share buyback program and will be funded with cash on hand. The offering is underwritten by Goldman Sachs & Co. LLC.

• · The selling stockholder will receive all net proceeds from the offering, including from the underwriter option.
• · The company will not receive any proceeds from the sale of shares by the selling stockholder.
• · The share repurchase is conditioned upon the closing of the offering, but the offering is not conditioned upon the repurchase.
• · The repurchase is part of the company's existing share repurchase program and will be funded with cash on hand.
• · Goldman Sachs & Co. LLC is the sole underwriter and will not receive compensation for the share repurchase.

10-09-2026

East West Ave Acquisition Corp. (EWAV) dismissed its independent auditor Fortune CPA, Inc. and appointed Golden Ocean FAC PAC as its new auditor for FY 2026, effective September 8, 2026. The change was approved by the Board and Audit Committee. There were no disagreements or reportable events with the former auditor, and the company had not consulted the new auditor on any accounting matters prior to engagement.

• · Company incorporated on October 30, 2025 (Inception).
• · Fortune CPA's reports from Inception through November 30, 2025 contained no adverse opinion, disclaimer, or qualification.
• · No disagreements or reportable events occurred during FY ended November 30, 2025 or the subsequent interim period through September 8, 2026.
• · Golden Ocean's PCAOB ID is 7285.
• · A letter from Fortune CPA to the SEC is filed as Exhibit 16.1.

10-09-2026

On September 3, 2026, New Fortress Energy Inc. appointed Frederick Hundt, its Chief Accounting Officer, as interim Chief Financial Officer while the Board conducts a search for a permanent CFO. Mr. Hundt will serve as both principal financial and principal accounting officer. The filing does not disclose any financial metrics or period-over-period comparisons, so no performance data is available.

• · Mr. Hundt joined NFE in June 2025 as Global Controller and became Chief Accounting Officer on July 1, 2026.
• · Prior to NFE, he served as Corporate Controller at GXO Logistics from April 2023 to June 2025.
• · He previously held finance leadership roles at Mastercard, including Assistant Corporate Controller, from 2015 to April 2023.

10-09-2026

Matador Resources Company announced the retirement of Van H. Singleton, II as Co-President – Land, Acquisitions and Divestitures and Planning, effective September 9, 2026. Singleton will transition to a Special Advisor role to the Board and Executive Committee, with an annual fee of $450,000 paid monthly, while his outstanding equity awards will continue to vest. Bryan A. Erman will assume the Co-President role, and Jonathan J. Filbert will take over Singleton's land and M&A responsibilities.

• · Singleton's role as Co-President assumed by Bryan A. Erman, who has served as Co-President, Chief Legal Officer and Head of M&A since June 2025.
• · Jonathan J. Filbert, Executive Vice President – Land since October 2023, will assume Singleton's land and acquisition/divestiture responsibilities.
• · The Advisor Agreement includes confidentiality, non-competition, and non-solicitation covenants.
• · The term of the Advisor Agreement continues until terminated by either party.

10-09-2026

Park Hotels & Resorts Inc. granted one-time retention restricted stock awards (RSA) to four named executive officers on September 3, 2026, to mitigate leadership transition and recruiting risks. CEO Thomas J. Baltimore, Jr. received 331,564 shares, while other executives received smaller grants. The awards vest fully on the fourth anniversary, with accelerated vesting provisions for certain termination scenarios.

• · The Retention RSA Awards vest in full on the fourth anniversary of the grant date, subject to continued employment.
• · For executives other than Mr. Baltimore, termination without cause or due to retirement after the first anniversary results in full vesting; termination without cause within 12 months following a change in control also results in full vesting; death or disability triggers prorated vesting based on actual days employed during the vesting period.
• · Mr. Baltimore's vesting upon termination is governed by his Executive Employment Agreement dated April 26, 2016.
• · Award recipients will receive dividends on the restricted shares at the same time as regular dividend payments on common stock.

10-09-2026

On September 9, 2026, Hertz appointed Michael Moore as President of the Service Division and Chris Berg as President of the Rental Division, both effective immediately. These executive transitions are part of the Company's new Platform Operating Model, which aligns the enterprise around four business areas: Rental, Fleet, Service, and Oro Mobility. No financial figures or period-over-period comparisons are included in this filing.

• · The new Platform Operating Model aligns the enterprise around four business areas: Rental, Fleet, Service, and Oro Mobility.
• · Both appointments were effective as of September 9, 2026.

10-09-2026

Autodesk priced a $1.0 billion debt offering split equally into $500 million 5.050% Notes due 2029 and $500 million 5.650% Notes due 2033. Proceeds, together with cash on hand, will repay a $1.0 billion term loan taken out in June 2026. The refinancing slightly raises Autodesk’s blended coupon rate from its previous loan terms, but extends maturities and locks in fixed-rate funding.

• · The offering was made under a Form S-3 shelf registration statement (File No. 333-287650).
• · Interest on both note series is payable semi-annually on March 15 and September 15, starting March 15, 2027.
• · The Notes are governed by an indenture dated December 13, 2012, as supplemented by a Seventh Supplemental Indenture dated September 10, 2026.
• · Autodesk may redeem the Notes early on specified terms and may be required to repurchase them upon a change in control coupled with a rating downgrade below investment grade.
• · Negative covenants restrict incurring liens on principal property, sale-and-leaseback transactions, and certain mergers/asset sales.
• · Events of default include payment failure, covenant breach, and insolvency events.
• · The proceeds from the Notes combined with cash on hand will fully repay a $1.0 billion term loan entered into on June 15, 2026.

10-09-2026

On September 10, 2026, Williams Companies completed a registered offering of $2.75 billion aggregate principal amount of Senior Notes across four tranches: $500 million of 5.000% notes due 2029, $1.0 billion of 5.600% notes due 2033, $750 million of 5.800% notes due 2036, and $500 million of 6.400% notes due 2056. The notes are senior unsecured obligations ranking equally with existing senior debt, and the indenture includes customary covenants and events of default with make-whole redemption provisions prior to certain dates. No period-over-period comparisons or mixed performance indicators are present as this is a debt issuance event.

• · The offering was registered under the Securities Act of 1933 pursuant to a Form S-3 registration statement (No. 333-277232) and a prospectus supplement dated September 8, 2026.
• · Interest on the 2029 Notes is payable semi-annually on April 15 and October 15, beginning April 15, 2027; interest on the 2033, 2036, and 2056 Notes is payable on March 15 and September 15, beginning March 15, 2027.
• · The notes may be redeemed at any time prior to specified dates (September 15, 2029 for 2029 Notes; July 15, 2033 for 2033 Notes; June 15, 2036 for 2036 Notes; March 15, 2056 for 2056 Notes) at a make-whole premium, and thereafter at par plus accrued interest.
• · The indenture was supplemented by the Fourteenth Supplemental Indenture dated September 10, 2026, with The Bank of New York Mellon Trust Company, N.A. as trustee.

10-09-2026

IBEX Ltd reported record fiscal year 2026 financial results with full-year revenue growing 15.4% to $644.1 million and adjusted EBITDA increasing 14.5% to $82.4 million. However, fourth quarter net income declined 8.8% to $8.7 million and adjusted EBITDA margin contracted 160 bps to 12.3% due to training costs and temporary work transfers. The company introduced fiscal year 2027 guidance with revenue expected between $700-$715 million (9-11% growth) and adjusted EBITDA between $90-$94 million (9-14% growth).

• · Q4 FY26 net income margin decreased 120 bps to 5.3% from 6.5% due to training costs for new client wins and temporary impact of work transferring from nearshore to offshore delivery centers.
• · Full-year FY26 adjusted EBITDA margin remained relatively flat at 12.8% vs 12.9% in FY25.
• · Capital expenditures increased 51.1% to $27.8 million in FY26 from $18.4 million in FY25, driven by offshore expansions and IT/telecom equipment purchases.
• · The company repurchased approximately 0.5 million shares for $14.4 million at an average price of $31.70 during FY26.
• · Fiscal year 2027 revenue guidance of $700-$715 million implies 9-11% growth, decelerating from the 15.4% growth in FY26.
• · First quarter FY27 revenue guidance of $168-$170 million implies 11-12% growth, slightly below the 11.6% growth in Q4 FY26.

10-09-2026

Reborn Coffee, Inc. expanded its Board of Directors from seven to eight members and appointed James Lim and Edward Park to fill vacancies, effective September 3, 2026. The appointments bring the Board to eight directors, with both new members serving without compensation and not assigned to any committee. No related-party transactions or arrangements were disclosed.

• · Board increased from 7 to 8 members on September 3, 2026.
• · Prior to appointments, the Board had 6 directors; two vacancies were filled.
• · Neither Mr. Lim nor Mr. Park will receive compensation for board service.
• · Neither new director has been appointed to any board committee.
• · No arrangements or understandings with other persons regarding their selection.
• · No reportable related-party transactions under Item 404(a) of Regulation S-K.

10-09-2026

NIKE held its 2026 Annual Meeting on September 8, 2026, where shareholders approved all management proposals, including the election of directors, an advisory vote on executive compensation, ratification of PwC as auditor, and an increase in shares under the Employee Stock Purchase Plan. However, the advisory vote on executive compensation received significant opposition (349.5 million votes against, or about 32% of votes cast), and two shareholder proposals—one regarding charitable support discrimination and another on environmental targets—were overwhelmingly rejected. The company also disclosed the adoption of an amended Employee Stock Purchase Plan, increasing authorized shares by 16 million.

• · All Class A directors were elected unanimously with 280,747,848 votes for each and zero votes withheld.
• · Class B director Thasunda Duckett received 496,775,961 votes for and 310,517,784 withheld, indicating notable opposition.
• · The advisory vote on executive compensation had 349,508,277 votes against (32% of votes cast), a significant level of dissent.
• · Shareholder proposals on charitable support discrimination and environmental targets were rejected with only 0.7% and 10.3% support, respectively.
• · The Employee Stock Purchase Plan amendment increases authorized shares by 16,000,000 and was approved with overwhelming support (1,081,095,618 for).
• · Ratification of PwC as auditor passed with 1,175,590,556 votes for and 58,924,987 against.

10-09-2026

First Internet Bancorp completed a private placement of $20.5 million in 8.0% fixed-to-floating rate subordinated notes due 2036. The notes qualify as Tier 2 capital and proceeds will be used for general corporate purposes, including potential redemption of higher-rate debt. The offering was placed by Piper Sandler & Co.

• · Notes are redeemable by the Company on or after September 15, 2031, and at any time upon occurrence of certain events.
• · Notes have not been registered under the Securities Act of 1933 and are not FDIC-insured.
• · First Internet Bancorp's common stock trades on Nasdaq Global Select Market under symbol INBK and is a component of the Russell 2000 Index.

10-09-2026

Galaxy Gaming, Inc. entered into an amended and restated employment agreement with CFO Steven Kopjo, extending his term through February 28, 2029. The agreement provides base compensation of $262,500 for the year ending August 31, 2027, increasing to $275,000 thereafter, along with a target annual bonus of 75% of base salary. Additionally, Kopjo received a stock option grant for 120,000 shares at $1.656 per share, vesting in three tranches through July 2029, and a conditional grant of 100,000 restricted shares contingent on metrics through December 31, 2028. No negative or declining financial performance metrics were reported in this filing.

• · The stock option vests in three equal tranches of 40,000 shares on July 25, 2027, July 25, 2028, and July 25, 2029.
• · The conditional restricted stock grant is based on metrics concluding on December 31, 2028, as established by the Board.
• · The employment agreement includes customary non-competition, non-solicitation, non-disclosure, and non-disparagement provisions.
• · The agreement was entered into on September 8, 2026, and is effective as of September 1, 2026.
• · The company's common stock trades on the OTCQB marketplace under the symbol GLXZ.

10-09-2026

AIM ImmunoTech Inc. entered into exchange agreements with Streeterville Capital, LLC on September 3-4, 2026, converting approximately $450,000 of an existing promissory note into 1,921,441 shares of common stock at an average conversion price of $0.234 per share. The conversion was previously approved by stockholders on July 15, 2026, and the shares were issued under an exemption from registration. This debt-to-equity conversion reduces the company's outstanding debt but dilutes existing shareholders.

• · The exchange agreements were executed on September 3 and September 4, 2026.
• · The conversion price was approximately $0.234 per share.
• · Stockholder approval was obtained at a special meeting on July 15, 2026.
• · The shares were issued under Section 3(a)(9) of the Securities Act, an exemption for exchanges with existing security holders without solicitation commissions.

10-09-2026

CVD Equipment Corporation announced a major restructuring plan, including discontinuing new system orders for its CVD equipment business and reducing its workforce by approximately half. The company expects a restructuring charge of $0.8M to $1.0M this quarter. Concurrently, President and CEO Emmanuel Lakios has left the company, and VP of Manufacturing Operations Warren Cheesman has been appointed Acting CEO. While the company has $23.5M in cash and no debt, the restructuring is driven by continued weakness in equipment orders, declining backlog, and ongoing operating losses in the CVD equipment division.

• · The company will no longer pursue new system orders for its CVD equipment business, transitioning to a spare parts, quartz, and services business.
• · The Board continues to evaluate opportunities to monetize assets, including its primary facility in Central Islip.
• · Warren Cheesman has over 30 years of experience in engineering, operations, quality, and strategic sourcing across semiconductor, medical device, and defense equipment industries.
• · The company had no debt as of the end of Q2 2026.

10-09-2026

Fortive Corporation appointed Susan L. Main to its Board of Directors, effective September 9, 2026, increasing the board size from eight to nine members. Ms. Main will also serve on the Audit Committee and is deemed independent and an audit committee financial expert. She will receive standard non-employee director compensation as previously disclosed.

• · Ms. Main's term expires at the 2027 Annual Meeting of Shareholders.
• · She has entered into an indemnification agreement with the company.
• · No arrangement or understanding exists between Ms. Main and any other person regarding her selection as director.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K were identified.

10-09-2026

Zedge, Inc. entered into a Securities Purchase Agreement on September 8 and 10, 2026, to sell an aggregate of 2,616,447 shares of Class B common stock and warrants to purchase 2,354,803 additional shares to Howard Jonas (Vice Chairman), Elliot Gibber (Board member), and another stockholder for total proceeds of $7,675,000. The purchase price per share is either $2.98 or $2.93, with 90% warrant coverage. The warrants have an exercise price of 110% of the purchase price ($3.22 or $3.28 per share), expire in five years, and are subject to a six-month lock-up and stockholder approval. No placement agent or underwriter was used, and the securities are unregistered.

• · The purchase price per share is either $2.98 or $2.93, equal to the closing price on the NYSE American on the trading day immediately preceding the respective Purchaser's execution of the Purchase Agreement.
• · Warrant coverage is 90% of the shares purchased.
• · Warrant exercise price is 110% of the purchase price per share ($3.22 or $3.28).
• · Warrants expire on the fifth anniversary of the initial exercise date.
• · Warrants may not be exercised before the later of six months after closing or receipt of stockholder approval under NYSE American rules.
• · Stockholder approval is not a condition to closing.
• · The Company has agreed to use reasonable best efforts to obtain stockholder approval at its next annual or special meeting.
• · Each Purchaser has agreed not to vote his/its Class B Common Stock on the stockholder approval proposal.
• · Warrants require cash exercise, are non-transferable, and will not be listed for trading.
• · No placement agent or underwriter was used; no underwriting discounts or commissions were paid.
• · The securities are being issued in reliance on Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.

10-09-2026

Bank7 Corp. (BSVN) has amended its Stock Purchase Agreement to acquire all shares of MCA Financial Group, LLC from a court-appointed receiver for a cash purchase price of $88.96 million, up from the original $68 million, following a competitive auction on September 3, 2026. The successful bid was $91 million, with a $2.04 million break-up fee credit applied. The transaction remains subject to court approval via a Sale Order.

• · The auction was conducted by the court-appointed receiver on September 3, 2026, after receiving more than one Qualified Bid.
• · Bank7 Corp. was declared the Successful Bidder.
• · The amendment was entered into on September 3, 2026, and filed on September 10, 2026.
• · The transaction is part of a receivership proceeding under the jurisdiction of an Arizona court.

10-09-2026

National Healthcare Properties, Inc. completed the first tranche of the sale of a portfolio of 86 outpatient medical facilities to an unaffiliated third party, closing on September 10, 2026. The first tranche included 30 properties, generating approximately $79 million in net cash proceeds before expenses and adjustments. The company also repaid approximately $119 million of outstanding secured indebtedness, including about $60 million of debt encumbering other outpatient medical facilities not part of this portfolio.

• · The sale was previously announced on May 4, 2026, under a Purchase and Sale of Real Property Agreement.
• · No material relationships exist between the sellers and the buyer other than this transaction.
• · The filing includes a cover page XBRL interactive data file as an exhibit.

10-09-2026

Kadant Inc. announced a CEO succession plan on September 10, 2026. Michael C. Colwell will become President and COO on October 1, 2026, and President, CEO, and a director on January 2, 2027, succeeding Jeffrey L. Powell, who will become Executive Chairman. Current Chairman Jonathan W. Painter will retire from the board on January 2, 2027. The plan ensures leadership continuity and retention of Mr. Powell for one year post-CEO transition.

• · Mr. Colwell has been a senior vice president since December 2024 and previously led the Industrial Processing segment.
• · Mr. Powell will serve as Executive Chairman for one year after stepping down as CEO, until his retirement on January 1, 2028.
• · Mr. Painter has served as chairman for the last seven years and will retire from the board on January 2, 2027.
• · The company has approximately 4,000 employees in 22 countries.

10-09-2026

TransMedics appointed Fernando Araujo as CFO effective September 21, 2026, succeeding Gerardo Hernandez who transitions to lead Latin American expansion. The company reiterated its full-year 2026 revenue guidance of $737M to $757M, representing 22%-25% YoY growth, while excluding any contribution from its recent investment in PAD Aviation Service GmbH.

• · Fernando Araujo previously served as CFO of GE HealthCare's Advanced Imaging Solutions segment, a $16B business.
• · Gerardo Hernandez will transition to Commercial Strategic Advisor, LATAM to lead TransMedics' expansion into Latin America.
• · The 2026 revenue guidance excludes any contribution from the recent strategic investment in PAD Aviation Service GmbH.
• · TransMedics management will present at Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026, and Baird 2026 Global Healthcare Conference on September 15, 2026.

10-09-2026

Ameresco, Inc. announced the designation of Julie Bradshaw as interim principal financial officer and Debbie Angelico as interim principal accounting officer, effective September 8, 2026, following the previously disclosed resignation of CFO Mark Chiplock (effective September 25, 2026). The company has commenced a search for a new CFO. Both appointees are internal Vice Presidents of Finance with no disclosed conflicts or family relationships.

• · Julie Bradshaw joined Ameresco in April 2014 and has been VP Finance since January 2026; prior roles include Accounting Supervisor at Enterprise Holdings.
• · Debbie Angelico joined Ameresco in August 2020 and has been VP Finance since January 2026; prior roles include Senior Manager of SEC Reporting at Covertus (1 year) and CFO of Next Level Now, Inc. (5 years).
• · No arrangements or understandings exist regarding the appointments, and no family relationships or material interests in reportable transactions were disclosed.